Anwar, E; Goldberg, E; Fraser, A; Acosta, CJ; Paul, M; Leibovici, L (2. januar 2014). »Vaccines for preventing typhoid fever«. The Cochrane database of systematic reviews. 1: CD001261. doi:10.1002/14651858.CD001261.pub3. PMID24385413.
Vos, Theo; in sod. (Global Burden of Disease Study 2013 Collaborators) (22. avgust 2015). »Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013«. Lancet (London, England). 38 (9995): 743–800. doi:10.1016/s0140-6736(15)60692-4. PMID26063472.
Yap, Kien-Pong; Ho, Wing S.; Gan, Han M.; Chai, Lay C.; Thong, Kwai L. (2016). »Global MLST of Salmonella Typhi Revisited in Post-genomic Era: Genetic Conservation, Population Structure, and Comparative Genomics of Rare Sequence Types«. Frontiers in microbiology. 7. doi:10.3389/fmicb.2016.00270.
Effa EE; Lassi ZS; Critchley JA; Garner P; Sinclair D; Olliaro PL; Bhutta ZA (2011). Bhutta, Zulfiqar A (ur.). »Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever)«. Cochrane Database Syst Rev (10): CD004530. doi:10.1002/14651858.CD004530.pub4. PMID21975746.
Soe GB; Overturf GD (1987). »Treatment of typhoid fever and other systemic salmonelloses with cefotaxime, ceftriaxone, cefoperazone, and other newer cephalosporins«. Rev Infect Dis. The University of Chicago Press. 9 (4): 719–736. doi:10.1093/clinids/9.4.719. JSTOR4454162. PMID3125577.
Wallace MR; Yousif AA; Mahroos GA; Mapes T; Threlfall EJ; Rowe B; Hyams KC (1993). »Ciprofloxacin versus ceftriaxone in the treatment of multiresistant typhoid fever«. Eur J Clin Microbiol Infect Dis. 12 (12): 907–910. doi:10.1007/BF01992163. PMID8187784.
Soe GB; Overturf GD (1987). »Treatment of typhoid fever and other systemic salmonelloses with cefotaxime, ceftriaxone, cefoperazone, and other newer cephalosporins«. Rev Infect Dis. The University of Chicago Press. 9 (4): 719–736. doi:10.1093/clinids/9.4.719. JSTOR4454162. PMID3125577.
Anwar, E; Goldberg, E; Fraser, A; Acosta, CJ; Paul, M; Leibovici, L (2. januar 2014). »Vaccines for preventing typhoid fever«. The Cochrane database of systematic reviews. 1: CD001261. doi:10.1002/14651858.CD001261.pub3. PMID24385413.
Vos, Theo; in sod. (Global Burden of Disease Study 2013 Collaborators) (22. avgust 2015). »Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013«. Lancet (London, England). 38 (9995): 743–800. doi:10.1016/s0140-6736(15)60692-4. PMID26063472.
Jackson, BR; Iqbal, S; Mahon, B (27. marec 2015). »Updated Recommendations for the Use of Typhoid Vaccine - Advisory Committee on Immunization Practices, United States, 2015«. MMWR. Morbidity and mortality weekly report. 64 (11): 305–308. PMID25811680.
Effa EE; Lassi ZS; Critchley JA; Garner P; Sinclair D; Olliaro PL; Bhutta ZA (2011). Bhutta, Zulfiqar A (ur.). »Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever)«. Cochrane Database Syst Rev (10): CD004530. doi:10.1002/14651858.CD004530.pub4. PMID21975746.
Soe GB; Overturf GD (1987). »Treatment of typhoid fever and other systemic salmonelloses with cefotaxime, ceftriaxone, cefoperazone, and other newer cephalosporins«. Rev Infect Dis. The University of Chicago Press. 9 (4): 719–736. doi:10.1093/clinids/9.4.719. JSTOR4454162. PMID3125577.
Wallace MR; Yousif AA; Mahroos GA; Mapes T; Threlfall EJ; Rowe B; Hyams KC (1993). »Ciprofloxacin versus ceftriaxone in the treatment of multiresistant typhoid fever«. Eur J Clin Microbiol Infect Dis. 12 (12): 907–910. doi:10.1007/BF01992163. PMID8187784.
Dutta P; Mitra U; Dutta S; De A; Chatterjee MK; Bhattacharya SK (2001). »Ceftriaxone therapy in ciprofloxacin treatment failure typhoid fever in children«. Indian J Med Res. 113: 210–213. PMID11816954.